Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 4 of the 6 sources its claims cite were checked for support.
Abstract
An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo. Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses. Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons, this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.
Overview
CoChat Summary
## TL;DR
In aged telomerase-deficient TERT-ER mice, a 4-week course of 4-OHT-induced telomerase reactivation reversed multiple degenerative phenotypes rather than merely halting them. The treatment restored telomere signal and reduced DNA damage responses, with functional recovery in testes, spleen, intestine, brain myelination, and innate olfactory behavior.
## Key findings
- G4 TERT-ER mice phenocopied late-generation telomerase-deficient mice and had reduced survival: median survival was 43.5 vs. 86.8 weeks for telomere-intact mice.
- After 4 weeks of 4-OHT, telomerase reactivation increased telomere-FISH signal, reduced p53 activation, reduced p21 expression, and decreased 53BP1 foci in splenocytes and intestinal crypt cells.
- Telomerase reactivation reversed tissue degeneration, including restoration of normal testes and spleen size, reduced apoptosis in testes germ cells and intestinal crypt cells, and increased fecundity.
- In the brain, treatment restored Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocytes; brain weight improved from 77.3 ± 3.3% to 89.7 ± 4.0% of G0 levels, and the myelin g-ratio shifted from 0.7756 ± 0.0054 in G4 mice toward 0.7058 ± 0.0006 after treatment.
- Innate olfactory avoidance recovered: untreated G4 mice failed to avoid lower 2-MB concentrations, but after 4-OHT they showed avoidance at all tested concentrations (1.87 × 10^-4 M to 1.87 × 10^-6 M).
## Methods
- The authors generated a knock-in TERT-ER mouse with a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-estrogen receptor fusion under the endogenous TERT promoter; studies used adult male mice, typically 30–35 weeks old, across successive generations (G0 to G4).
- They assessed telomerase activity, telomere status, DNA damage markers, histology, neurosphere self-renewal and differentiation, myelination, and olfactory behavior using TRAP assays, IHC/FISH, cell culture, electron microscopy, and behavioral testing.
- Statistical analysis used one-way ANOVA with Bonferroni post test and Mantel-Cox tests for survival curves.
## Limitations
- The paper states that carcinogenesis was not observed after the brief telomerase reactivation course, but also notes this was “data not shown” and that longer or later-life reactivation may provoke carcinogenesis.
- The study was performed on adult males only, so the text makes evident a sex limitation.
- The olfactory test sample sizes were small in the methods (n=4 per experimental condition), which is evident from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
3 Valid · 0 Not valid · 1 Not checked · 19 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thus, G4 TERT-ER mice phenocopy late generation mTert -/- and mTerc -/- animals 13 , 14 , indicating that TERT-ER is inactive in the absence of 4-OHT.”
What the sources say
- Partly supportedcites [13] Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997) sourceExperimental — accuracy not yet measured
The Abstract reports progressive telomere loss and frequent chromosomal rearrangements in later generations of mTR−/− mice, supporting the comparison to mTerc−/− animals. It does not study mTert−/− or TERT-ER mice, so it cannot establish that G4 TERT-ER mice phenocopy both groups. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [14] Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643–648 (2003) source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocyte populations.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with the integral role of SVZ neural progenitors in generation and maintenance of olfactory bulb interneurons 2 , this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Figure 2. Telomerase activation in adult TERT-ER mice”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocyte populations.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
13 more claims
Create a free account to see all 23 claims and every source verdict.
- It may state two separate claims as one. 2
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice, segmental premature ageing only manifest in telomerase mutants after several generations, likely because their particularly long telomeric repeats take several generations to become critically shortened and thus dysfunctional16.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“neural stem cells from mTERC-reactivated animals showed enhanced multipotency, suggesting recovered neurogenic function.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice with telomerase deficiency serve as a robust model for studying anti-aging effects as they closely resemble natural aging and reflect various pathophysiological states during the aging process, making them more representative compared to other aging mouse models induced by different methods (Jaskelioff et al., 2011).”
From Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model (2023) · cites this paper as Jaskelioff et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, in post-mitotic neurons, restoration of physiological TERT levels improve capacity for neural stem cell regeneration, enhance synaptic plasticity and preserve cognitive function in two models of Alzheimer’s Disease.15,16”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, in genetically engineered mice, TERT reactivation studies revealed the dual role of TERT in the reversal of aging via telomere synthesis in proliferative tissues as well as via gene expression modulation in post-mitotic tissues in a telomere-independent manner.”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [15]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Innate olfactory avoidance test
“For innate avoidance tests, circular filter paper (2.5cm diameter) was scented with 40 μl of either water or progressively higher concentrations of 2-MB (1.74 × 10 -6 M through 1.74 × 10 -4 M)”
§ Abstract
“Whereas G0 TERT-ER mice demonstrated avoidance responses at all 2-MB concentrations tested (1.87×10 -4 M through 1.87×10 -6 M), G4 mice showed attraction/neutral behaviors at concentrations lower than 1.87×10 -4 M (Figure 5e,f).”
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,104
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Self-citationLinking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759
Self-citationHow stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
Self-citationInnate versus learned odour processing in the mouse olfactory bulb
Kobayakawa, K., Kobayakawa, R., Matsumoto, H., Oka, Y., Imai, T., Ikawa, M., Okabe, M., Ikeda, T., Itohara, S., Kikusui, T., et al. (2007) · Nature · doi:10.1038/nature06281 · Cited by 671
Chan, S. R. W. L., & Blackburn, E. H. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1370 · Cited by 595
Cited by
Items 301–400 of 848
Rodríguez‐Fernández, B., Vilor‐Tejedor, N., Arenaza‐Urquijo, E. M., Sánchez‐Benavides, G., Suárez‐Calvet, M., Operto, G., Minguillón, C., Fauria, K., Kollmorgen, G., Suridjan, I., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01101-9 · Cited by 34
“, the enzyme that maintains TL in the cell) reversed brain tissue degeneration among aged telomerase-deficient mice [78].”
BackgroundTelomerase expression in amyotrophic lateral sclerosis (ALS) patients
Felice, B. D., Annunziata, A., Fiorentino, G., Manfellotto, F., D‘Alessandro, R., Marino, R., Borra, M., & Biffali, E. (2014) · Journal of Human Genetics · doi:10.1038/jhg.2014.72 · Cited by 35
Wang, Y., Wang, Y., Yang, M., & Ma, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111191 · Cited by 34
The central role of DNA damage in immunosenescence
Kell, L., Simon, A. K., Alsaleh, G., & Cox, L. S. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1202152 · Cited by 49
“, 2000), while experimental telomerase reactivation promotes tissue rejuvenation in mice (Jaskelioff et al., 2011).”
BackgroundMetabolism, longevity and epigenetics
Cosentino, C., & Mostoslavsky, R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1295-3 · Cited by 40
“Remarkably, the progeroid phenotype observed in mTERT-deficient animals is basically reversed by inducing the re-expression of mTERT in vivo [123].”
Ovarian Telomerase and Female Fertility
Toupance, S., Fattet, A.-J., Thornton, S. N., Bénétos, A., Guéant, J., & Koscinski, I. (2021) · Biomedicines · doi:10.3390/biomedicines9070842 · Cited by 38
“Moreover, in aged telomerase-deficient mice, telomerase reactivation reversed tissue degeneration and allowed the restoration of animal fertility [114].”
BackgroundStem Cell Ageing and Apoptosis
Fulle, S., Centurione, L., Mancinelli, R., Sancilio, S., Manzoli, F. A., & Pietro, R. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799859657 · Cited by 34
“Interestingly, in a recently published paper the group of Ronald DePinho reported the observation of a diffuse tissue rejuvenation of the testes, spleen, liver, intestines and brain of genetically modified mice, designed to restore telomerase activity after feeding them with a chemical [60].”
BackgroundMicroenvironmental Regulation of Telomerase Isoforms in Human Embryonic Stem Cells
Radan, L., Hughes, C. S., Teichroeb, J. H., Zamora, F., Jewer, M., Postovit, L.-M. M., & Betts, D. H. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0373 · Cited by 37
“Telomer-ase activation by transgenic [19,20] or pharmacological means [21] can reverse tissue degeneration and increase health span in aged mice.”
Inhibitory effects of (−)-loliolide on cellular senescence in human dermal fibroblasts
Yang, H. H., Hwangbo, K., Zheng, M. S., Cho, J. H., Son, J., Kim, H. Y., Baek, S. H., Choi, H. C., Park, S., & Kim, J. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0435-0 · Cited by 34
“Furthermore, inhibition of cellular senescence or removal of senescent cells in vivo has been reported to preclude or postpone age-related tissue dysfunction and increase health life-span (Jaskelioff et al. 2011).”
BackgroundWeilner, S., Grillari‐Voglauer, R., Redl, H. R., Grillari, J., & Nau, T. (2014) · Acta Orthopaedica · doi:10.3109/17453674.2014.957079 · Cited by 37
“Furthermore, the influence of senescent cells in aging of an organism was also shown by reactivating telomerase in mouse tissues, which subsequently “became rejuvenated” (Jaskelioff et al. 2011, Bernardes de Jesus et al. 2012).”
BackgroundWhy stem/progenitor cells lose their regenerative potential
Picerno, A., Stasi, A., Franzin, R., Curci, C., di Bari, I., Gesualdo, L., & Sallustio, F. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i11.1714 · Cited by 36
Ni, Y., Wu, T., Yang, L., Xu, Y., Ota, T., & Fu, Z. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0500 · Cited by 32
Characteristics of cardiac aging in C57BL/6 mice
Cheng, Z., Ito, S., Nishio, N., Thanasegaran, S., He, F., & Isobe, K. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.01.005 · Cited by 34
“Telomere shortening has traditionally been considered an important factor in aging (Bell and Sharpless, 2007; Gomes et al., 2011; Hagelstrom et al., 2010; Jaskelioff et al., 2011).”
BackgroundAccelerated biological aging in serious mental disorders
Wolkowitz, O. M. (2018) · World Psychiatry · doi:10.1002/wps.20546 · Cited by 35
Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases
Hong, J., & Yun, C. (2019) · Cells · doi:10.3390/cells8050392 · Cited by 35
“Although these discrepancies in the oncogenic potential of ectopically expressed TERT require more extensive evaluation in the future, there is a telomerase-deficient TG mouse model [11] that supports the findings achieved by the TERT transfer of AAV9.”
BackgroundResultTelomere Biology in Mood Disorders: An Updated, Comprehensive Review of the Literature
Muneer, A., & Minhas, F. A. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.3.343 · Cited by 35
Li, J., Tang, B., Qu, Y., & Mu, D. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.07.010 · Cited by 30
“A very recent study revealed telomerase activity reactivated by TERT in telomerase deficient mice promoted neurogenesis, proliferation and differentiation of NPCs (Jaskelioff et al., 2011).”
BackgroundInfluentialPromotion of Lung Health: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
Camargo, C. A., Budinger, G. R. S., Escobar, G. J., Hansel, N. N., Hanson, C., Hu, B., & Buist, A. S. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-451ld · Cited by 32
How does the body know how old it is? Introducing the epigenetic clock hypothesis
Mitteldorf, J. J. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913090113 · Cited by 31
Barros, P. R., Costa, T. J. D., Akamine, E. H., & Tostes, R. C. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.727604 · Cited by 34
Tieing together loose ends: telomere instability in cancer and aging
Borges, G. D. O., Criqui, M., & Harrington, L. A. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13299 · Cited by 37
Lü, X., Agasti, S. S., Vinegoni, C., Waterman, P. G., DePinho, R. A., & Weissleder, R. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300319c · Cited by 30
Self-citationMolano, A., Huang, Z., Marko, M. G., Azzi, A., Wu, D., Wang, E. L., Kelly, S. L., Merrill, A. H., Bunnell, S. C., & Meydani, S. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047650 · Cited by 31
“This produces genotoxic stresses that provoke widespread p53 activation [38].”
BackgroundLai, A. G., Pouchkina-Stantcheva, N. N., Donfrancesco, A. D., Kildisiute, G., Sahu, S., & Aboobaker, A. A. (2017) · BMC Evolutionary Biology · doi:10.1186/s12862-017-0949-4 · Cited by 32
Bressler, J., Franceschini, N., Demerath, E. W., Mosley, T. H., Folsom, A. R., & Boerwinkle, E. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0194-x · Cited by 28
“Similarly, restoration of telomerase activity in Terc-deficient mice resulted in longer telomeres and absence of premature aging [38], and alleviated the tissue degeneration and activation of DNA damage signaling that are characteristic consequences of telomere loss [39].”
BackgroundEssential roles for Pot1b in HSC self-renewal and survival
Wang, Y., Shen, M., & Chang, S. S. (2011) · Blood · doi:10.1182/blood-2011-06-361527 · Cited by 31
Morange, M. (2011) · Biological Theory · doi:10.1007/s13752-011-0010-6 · Cited by 32
“The artificial reactivation of telomerase reverses the tissue damage observed in telomerase-deficient mice (Jaskellioff et al. 2011).”
BackgroundXanthohumol exerts protective effects in liver alterations associated with aging
Fernández-García, C., Rancán, L., Paredes, S. D., Montero, C., la Fuente, M. D., Vara, E., & Tresguerres, J. A. F. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1657-6 · Cited by 31
“It is also considered that a reduction in hepatocyte telomere length results in diminished cell mitosis and apoptosis, and therefore, in a decrease in cell proliferation [4, 5].”
BackgroundRole of angiotensin II in aging
Yi, W., Chen, F., Zhang, H., Tang, P., Yuan, M., Wen, J., Wang, S., & Cai, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1002138 · Cited by 35
“Finally, an experiment proved that reactivation of the telomerase gene could reverse premature aging in telomeraselack mice (Jaskelioff et al., 2011).”
Denham, J. (2023) · Aging Cell · doi:10.1111/acel.13836 · Cited by 28
Conserved epigenetic hallmarks of T cell aging during immunity and malignancy
Tian, M., Soerens, A. G., Alli, S., Kang, T. G., Vasandan, A. B., Wang, Z., Vezys, V., Kimura, S., Iacobucci, I., Baylin, S. B., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00649-5 · Cited by 35
“Specifically, accumulation of age-associated changes in telomere length and somatic mutations have been reported as a surrogate for senescence and cellular lifespan 1–3 .”
Navigating oligodendrocyte precursor cell aging in brain health
Leenders, F., Koole, L., Slaets, H., Tiane, A., van den Hove, D., & Vanmierlo, T. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111959 · Cited by 35
“In addition to a low proliferation rate, the senescent state is recognized by the secretion of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP).”
BackgroundThe Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 31
“Given that the progression of the cellular senescence program through temporally and spatially separable steps imposes antagonistically pleiotropic effects on aging and cancer (Figures 1 and 2), what therapeutic interventions have a potential to be used not only for enhancing those effects that are anti-aging and/or a…”
BackgroundStochastic modeling of length-dependent telomere shortening in Corvus monedula
Grasman, J., Salomons, H. M., & Verhulst, S. (2011) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2011.04.026 · Cited by 30
Chiu, W., Carlsson, T., Depboylu, C., Höglinger, G. U., Oertel, W. H., & Ries, V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.014 · Cited by 27
“Although adult-born neurons in the OB are thought to relate to olfactory function, the impact of these adult-born neurons integrating into OB circuitry on functional outcome remains uncertain (Imayoshi et al., 2008; Jaskelioff et al., 2011; Lazarini et al., 2009; Mouret et al., 2009; Sakamoto et al., 2011).”
Reproductive aging and telomeres: Are women and men equally affected?
Chico-Sordo, L., Córdova-Oriz, I., Polonio, A. M., S-Mellado, L. S., Medrano, M., García-Velasco, J. A., & Varela, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111541 · Cited by 27
Biomarkers of Aging and Relevant Evaluation Techniques: A Comprehensive Review
Xue, T., Zhu, Z., Wang, L., Li, C., Sun, L., Wang, W., & Gong, W. (2024) · Aging and Disease · doi:10.14336/ad.2023.00808-1 · Cited by 63
“Similarly, telomerase reactivation in TERT-ER mice extended telomeres, reduced DNA damage signaling, and reversed degenerative phenotypes in multiple organs [28].”
BackgroundGenetic and epigenetic alterations in aging and rejuvenation of human
Park, K., Jeon, M. C., Lee, D., Kim, J., & Im, S.-W. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100137 · Cited by 37
Lv, X., Wang, X., Wang, Y., Zhou, D., Li, W., Wilson, J. X., Chang, H., & Huang, G. (2019) · Aging · doi:10.18632/aging.102461 · Cited by 29
“Late generation telomerase-deficient mice showed neuronal loss in the hippocampal region and frontal cortex associated with short-term memory deficits [19], impaired olfaction [20], and anxiety-like behaviors [21], while telomerase reactivation in adult mice was able to delay and reverse age-related decline in cogniti…”
BackgroundStem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency
Polonio, A. M., García-Velasco, J. A., & Herraiz, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.626322 · Cited by 36
“Concerning this pathway, the reactivation of telomerase—which maintains telomere length—has been described to resume fertility in telomerase-deficient mice, which present impaired fertility (57, 58), opening a new future possibility to ovarian rejuvenation by means of telomerase reactivation (59–61).”
BackgroundPangrazzi, L., & Meryk, A. (2024) · Biology · doi:10.3390/biology14010017 · Cited by 41
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Shou, S., Maolan, A., Zhang, D., Jiang, X., Liu, F., Li, Y., Zhang, X., Geer, E., Pu, Z., Hua, B., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00597-9 · Cited by 31
Walking the Walk from Genes through Telomere Maintenance to Cancer Risk
Blackburn, E. H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0066 · Cited by 26
“A recent study in aged telomerasedeficient mice showed that telomere reactivation through knock-in of an inducible telomerase component (TERT) gene resulted in a marked reversal of their phenotypes of degenerative disease, suggesting that restoring telomere integrity may have clinical implications for preventing aging…”
BackgroundDiet and longevity: The effects of traditional eating habits on human lifespan extension
Caprara, G. (2018) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-180225 · Cited by 27
“However, a compensatory mechanism for the reduction of telomere length exists that is based on the action of telomerase, a specific enzyme able to catalyze the lengthening of these repeated DNA structures [31, 32].”
Backgroundde Baca, T. C., Prather, A. A., Lin, J., Sternfeld, B., Adler, N. E., Epel, E. S., & Puterman, E. M. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0482-5 · Cited by 26
“Animal research implicates telomeric shortening in cellular damage and mortality [9, 10].”
BackgroundImpact of Ovarian Aging in Reproduction: From Telomeres and Mice Models to Ovarian Rejuvenation.
Polonio, A. M., Chico-Sordo, L., Córdova-Oriz, I., Medrano, M., García-Velasco, J. A., & Varela, E. (2020) · The Yale Journal of Biology and Medicine · Cited by 46
Deng, L., Shi, Q., Chen, C., Xiaolei, L., Lixing, Z., Zuo, Z., & Birong, D. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.527658 · Cited by 31
“Furthermore, genetics might be a potential confounder in such a correlation in view of the heritable characteristics of LTL (Jeanclos et al., 2000; Nawrot et al., 2004).”
BackgroundRejuvenating Strategies of Tissue-specific Stem Cells for Healthy Aging
Wang, M., Chen, J., Chen, F., Liu, Q., Sun, Y., Chen, Y., Yang, T., Bao, Y., & Hu, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.1119 · Cited by 27
“Notably, neural stem cells from telomerase RNA component mTERC-reactivated animals also restore their proliferative capacity and recover neurogenic function [54].”
BackgroundStructure, Topology, and Stability of Multiple G-quadruplexes in Long Telomeric Overhangs
Shiekh, S. A., Kodikara, S. G., & Balci, H. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168205 · Cited by 26
Wang, J., Liu, W., Huang, Y., Wang, G., Guo, X., Shi, D., Sun, T., Xiao, C., Zhang, C., Jiang, B., et al. (2024) · Advanced Science · doi:10.1002/advs.202401862 · Cited by 29
Ahmad, A., Braden, A. A., Khan, S., Xiao, J., & Khan, M. M. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01016-7 · Cited by 35
“…decline of stabilization in genetic telomere length is a crucial contributor to organismal aging leading to human telomeropathies accompanied by the appearance of various diseases such as congenital dyskeratosis, aplastic anemia, and pulmonary and liver disease with many progeroid features [36 ].”
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I. A., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 35
Oncogene‐induced senescence and melanoma: where do we stand?
Peeper, D. S. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00933.x · Cited by 31
“And very recent results indicate an intriguing connection between melanocyte senescence and competitive endogenous RNAs (ceRNAs) in BRAFE600-driven melanomagenesis (Karreth et al., 2011).”
BackgroundStem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury
Lee, J.-Y., Xu, K., Nguyen, H., Guedes, V. A., Borlongan, C. V., & Acosta, S. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00051 · Cited by 28
“…into injured organs is associated with therapeutic benefits (Mazzocchi-Jones et al., 2009; Hargus et al., 2010; Lee et al., 2010; Andres et al., 2011; Borlongan, 2011; Barha et al., 2011; Jaskelioff et al., 2011; Liu et al., 2011; Mezey, 2011; Wang et al., 2011; Yasuda et al., 2011).”
BackgroundInfluentialThe role of telomere-binding modulators in pluripotent stem cells
Li, F., Ge, Y., Liu, D., & Songyang, Z. (2019) · Protein & Cell · doi:10.1007/s13238-019-0651-y · Cited by 26
Guo, W., Lu, J., Dai, M., Wu, T., Yu, Z., Wang, J., Chen, W., Shi, D., Yu, W., Xiao, Y., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2430 · Cited by 24
“High activity of telomerase has been implicated in maintaining telomere stability, genome integrity, cell activity, potential longterm proliferative ability and other aspects in cancer cells [4,5].”
BackgroundCellular and molecular longevity pathways: the old and the new
Nikoletopoulou, V., Kyriakakis, E., & Tavernarakis, N. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.12.003 · Cited by 29
Drug-induced premature senescence model in human dental follicle stem cells
Zhai, Y., Wei, R., Liu, J., Wang, H., Cai, W., Zhao, M., Hu, Y., Wang, S., Yang, T., Liu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14085 · Cited by 26
“It is now clear that activing DNA repair machinery in stem cells may delay the age-associated defective accumulation and then drive aged tissues to recover healthy function, particularly if such an intervention might happen before the establishment of damaged DNA in the genome [28].”
BackgroundWithania somnifera Root Extract Enhances Telomerase Activity in the Human HeLa Cell Line
Raguraman, V., & Subramaniam, J. R. (2016) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2016.74018 · Cited by 30
“More importantly, nervous system, where neurons are thought to be differentiated and stay that way for a lifetime, manifests remarkable improvement from the degeneration [4].”
BackgroundOmics biomarkers for frailty in older adults
Pan, Y., Ji, T., Li, Y., & Ma, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.057 · Cited by 32
Progress of clinical evaluation for vascular aging in humans
Qiu, Y., Liu, Y., & Tao, J. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0002 · Cited by 25
“Recent evidence indicated that vascular aging can be reverted by telomerase activation, and normal physiological aging can be delayed by systemic viral transduction of telomerase.[49-51] Further insight into the underlining mechanisms of telomerase is, therefore, fundamental for both the prevention and the development…”
BackgroundTelomerase reverse transcriptase and neurodegenerative diseases
Yu, X., Liu, M., Zheng, C., Liu, Y., Wang, Z., & Wang, Z.-Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1165632 · Cited by 29
“As such, TERT has emerged as a promising strategy for the treatment of age-related NDs (30, 31) Research has shown that telomerase activation promotes lymphocyte proliferation and slows down cellular senescence, while TERT upregulation prevents or reverses tissue and organ degeneration and premature aging in mice (11).”
BackgroundAging by Telomere Loss Can Be Reversed
de Jesus, B. B., & Blasco, M. A. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.013 · Cited by 25
Remyelinating strategies in multiple sclerosis
Luessi, F., Kuhlmann, T., & Zipp, F. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.969241 · Cited by 25
“It has been shown that telomerase reactivation reverses ageassociated defects in neural stem cells [214], lending weight to the idea that aged OPC, in theory, keep their capacity for efficient remyelination.”
BackgroundZhou, Q.-G., Wu, H.-Y., Zhou, H., Liu, M.-Y., Lee, H. W., Liu, X., Devkota, S., Ro, E., Zhu, D.-Y., & Suh, H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.106 · Cited by 26
Energy excess is the main cause of accelerated aging of mammals
Biliński, T., Paszkiewicz, T., & Zadrąg‐Tęcza, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4271 · Cited by 26
“• Glyco/lipotoxicity [51, 66] • An excess of EMS system activity, eliminating or lowering expression of genes necessary for body maintenance of no longer growing adult organisms [67] • Lowering the reproductive capacity of some somatic cells by lack of telomerase activity in some types of somatic cells because gene th…”
BackgroundNoh, H. J., Yang, H. H., Kim, G., Lee, S. E., Lee, D., Choi, J. H., Kim, S. Y., Lee, E. S., Ji, S. H., Kang, K. S., et al. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.995181 · Cited by 24
“Six compounds were isolated and identified as hericenone D (1), (22E,24R)-5a,8aepidioxyergosta-6,22-dien-3b-ol (2), erinacerin B (3), hericenone E (4), hericenone F (5) and isohericerin (6) by comparing their spectroscopic data with previously reported values.”
BackgroundMethodGüneşliol, B. E., Karaca, E., Ağagündüz, D., & Acar, Z. A. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1952402 · Cited by 24
A Unified Model of Age-Related Cardiovascular Disease
Fossel, M., Bean, J., Khera, N., & Kolonin, M. G. (2022) · Biology · doi:10.3390/biology11121768 · Cited by 26
“Cell aging has been theorized [53,54,56,60] and implicated in age-related disease in animals [61,62] and humans [50,63].”
BackgroundNew Insights into the Genetics and Epigenetics of Aging Plasticity
Zhang, J., Wang, S., & Liu, B. (2023) · Genes · doi:10.3390/genes14020329 · Cited by 23
The role of Sirtuin 1 and its activators in age-related lung disease
Sun, C., Bai, S., Liang, Y., Liu, D., Liao, J., Chen, Y., Zhao, X., Wu, B., Huang, D., Chen, M., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114573 · Cited by 37
Shining the Light on Senescence Associated LncRNAs
Ghanam, A. R., Xu, Q., Ke, S., Azhar, M., Cheng, Q., & Song, X. (2017) · Aging and Disease · doi:10.14336/ad.2016.0810 · Cited by 26
Dysfunctional telomeres and hematological disorders
Fiorini, E., Santoni, A., & Colla, S. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.001 · Cited by 26
“…reactivation in a mouse model of telomere shortening with intact checkpoint signaling and advanced degenerative phenotypes alleviated DNA damage signaling–induced cellular checkpoint responses in multiple high-turnover organ systems without inducing cancer formation (Jaskelioff et al., 2011).”
BackgroundMethodInfluentialThe effect of age on stem cell function and utility for therapy
Narbonne, P. (2018) · Cell Medicine · doi:10.1177/2155179018773756 · Cited by 33
Peering through zebrafish to understand inherited bone marrow failure syndromes
Oyarbide, U., Topczewski, J., & Corey, S. J. (2018) · Haematologica · doi:10.3324/haematol.2018.196105 · Cited by 23
“short telomeres and increased sarcopenia, impaired cell proliferation and DNA damage.(98) accumulation of senescence cells.”
BackgroundTelomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics
Smith‐Sonneborn, J. (2019) · Current Aging Science · doi:10.2174/1874609812666190620124324 · Cited by 25
No Time to Age: Uncoupling Aging from Chronological Time
Larocca, D., Lee, J., West, M. D., Labat, I., & Sternberg, H. (2021) · Genes · doi:10.3390/genes12050611 · Cited by 24
“Importantly, reactivation of telomerase in this model restores degenerative damage in multiple systems, including neurodegeneration [33].”
BackgroundTelomeric Repeat Containing RNA (TERRA): Aging and Cancer
Sinha, S., Shukla, S., Khan, S. U., Farhan, M., Kamal, M. A., & Meeran, S. M. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150317230124 · Cited by 24
“Telomerase is highly active in developing brain and some specific regions of adult brain and has been shown to exhibit neuroprotective properties in experimental models of neurodegenerative disorders [56-59].”
BackgroundLi, B., Xiong, W., Zuo, W., Shi, Y., Wang, T., Chang, L., Wu, Y., Ma, H., Bian, Q., & Chang, A. C. Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae274 · Cited by 27
“Short telomeres have been implicated in pathologies associated with human aging, particularly in proliferative or regenerative organs ( 13–15 ).”
TIN2-mediated reduction of mitophagy induces RPE senescence under high glucose
Zhang, S., Chen, S., Sun, D., Li, S., Sun, J., Gu, Q., Liu, P., Wang, X., Zhu, H., Xu, X., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111188 · Cited by 26
Duncan, K., Gonzales-Portillo, G. S., Acosta, S. A., Kaneko, Y., Borlongan, C. V., & Tajiri, N. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.007 · Cited by 25
Remyelination: A Potential Therapeutic Strategy for Alzheimer’s Disease?
Sun, J., Zhou, H., Bai, F., Zhang, Z., & Ren, Q. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170036 · Cited by 27
Telomere biology disorders: time for moving towards the clinic?
Batista, L. F. Z., Dokal, I. S., & Parker, R. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.08.001 · Cited by 27
Function and treatment strategies of β-hydroxybutyrate in aging
Xiang, Y., Wang, Q., Lan, X., Zhang, H., & Wei, D. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.09.003 · Cited by 32
Telomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
“…fertility, deficient adaptive immunity, impaired memory, hindered healing of wounds, reduced stress reactions, increased graying of the hair and alopecia, reduced cardiac performance, weakened skeletal structure, higher incidence of cancer, and general frailty [55, 57, 123, 124, 126, 135, 188–190].”
Organ aging and susceptibility to cancer may be related to the geometry of the stem cell niche
Blagoev, K. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106105108 · Cited by 24
“Although contributing to aging, proliferative senescence also serves as a cancer protective mechanism by limiting the number of mutations that a cell can acquire as well as protecting cells with critically short telomeres from chromosome instability (20).”
BackgroundIskandar, M., Barbero, M. X., Jaber, M. T., Chen, R., Gomez-Guevara, R., Cruz, E., & Westerheide, S. D. (2025) · Cancers · doi:10.3390/cancers17020257 · Cited by 35
Maddison, D. R., & Anderson, R. (2016) · Deutsche Entomologische Zeitschrift · doi:10.3897/dez.63.10748 · Cited by 21
In medio stat virtus : unanticipated consequences of telomere dysequilibrium
Harrington, L. A., & Pucci, F. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0444 · Cited by 23
The secrets of telomerase: Retrospective analysis and future prospects
Kamal, S., Junaid, M., Ejaz, A., Bibi, I., Akash, M. S. H., & Rehman, K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118115 · Cited by 23
The Ethical and Social Dilemma of AI Uses in the Construction Industry
Arroyo, P., Schöttle, A., & Christensen, R. (2021) · Annual Conference of the International Group for Lean Construction · doi:10.24928/2021/0188 · Cited by 22
Molecular and chemical genetic approaches to developmental origins of aging and disease in zebrafish
Sasaki, T., & Kishi, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.030 · Cited by 24
“now reasonable to propose that the new direct link between theses mechanistic regulations have a crucial impact on balancing regeneration/rejuvenation and cancer during the aging process beyond embryogenesis [90].”
BackgroundTelomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan
Diao, D., Wang, H., Li, T., Shi, Z., Jin, X., Sperka, T., Zhu, X., Zhang, M., Yang, F., Cong, Y., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745494 · Cited by 22
“Deletion of DDR components or restoration of the telomerase activity restores the function of adult stem cells, thereby improving tissue homeostasis and alleviating premature aging symptoms in G3 Terc (cid:1) / (cid:1) mice [11 – 14].”
Germann, C. B. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109406 · Cited by 22
What Prolongs a Butterfly's Life?: Trade-Offs between Dormancy, Fecundity and Body Size
Haeler, E., Fiedler, K., & Grill, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111955 · Cited by 23
“Why some animals grow very old and others do not is still a challenge to biological science, despite massive ongoing research especially on humans [1,2,3,4,5], other vertebrates [6,7,8,9,10] and also on some invertebrate groups like Drosophila and”
BackgroundSheldon, E. L., Ton, R., Boner, W., Monaghan, P., Raveh, S., Schrey, A. W., & Griffith, S. C. (2021) · Molecular Ecology · doi:10.1111/mec.16187 · Cited by 20
Horizons in Human Aging Neuroscience: From Normal Neural Aging to Mental (Fr)Agility
Ridderinkhof, K. R., & Krugers, H. J. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.815759 · Cited by 30
Murillo-Ortiz, B. O., Albarrán-Tamayo, F., López-Briones, S., Martínez-Garza, S., Benítez-Bribiesca, L., & Arenas-Aranda, D. J. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-99 · Cited by 20
“Induction of telomerase activity that allows indefinite cell proliferation has been documented in different human cells [12].”
Stem cell function and maintenance – ends that matter: Role of telomeres and telomerase
Saeed, H., & Iqtedar, M. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9346-3 · Cited by 24
“showed that in vivo telomerase reactivation reversed neuro-degeneration in aged telomerase-deficient mice with restoration of Sox2 neural progenitors, DCX newborn neurons and Olig2 oligo-dendrocyte populations (Jaskelioff et al. 2011).”
BackgroundThe Rejuvenation of Aged Stem Cells for Cardiac Repair
Lüdke, A., Li, R., & Weisel, R. D. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.021 · Cited by 19
Metadata
- Authors
- Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., Horner, J. W., Maratos-Flier, E., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2010-11-28
- Volume
- 469
- Issue
- 7328
- Pages
- 102-106
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3057569
- OpenAlex
- W2053352181
- Semantic Scholar
- e8979f16fd203e2da6b0b4ab00099b85b2df9b18
- Cited by
- 857
- References
- 36
- Citations by year
- 2026: 33 · 2025: 42 · 2024: 43 · 2023: 45 · 2022: 43 · 2021: 80 · 2020: 45 · 2019: 54 · 2018: 45 · 2017: 60 · 2016: 55 · 2015: 49 · 2014: 62 · 2013: 70 · 2012: 67
- FWCI
- 43.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (U01CA141508, R01CA084628)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomerase reactivation, telomere elongation, telomere dysfunction, aging, tissue degeneration, DNA damage signaling, regenerative therapy, stem cell depletion, cellular senescence, carcinogenesis risk
- MeSH terms
- Doublecortin Protein, Aging, Animals, Avoidance Learning, Brain, Cell Differentiation, Cells, Cultured, DNA Damage, Enzyme Activation, Enzyme Reactivators, Mice, Inbred C57BL, Myelin Sheath, Organ Size, Phenotype, Receptors, Estrogen, Recombinant Fusion Proteins, Smell, Tamoxifen, Telomere, Telomerase, Models, Animal, Regenerative Medicine, Cell Proliferation, Mice, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.